# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 105


In regulation 137 (amendment of regulation 171 (exempt advanced therapy medicinal products)), for “substitute “regulation 49(1)”.” substitute—
“substitute—
“—
(i) in the case of a product for sale or supply in Northern Ireland, Regulation (EC) No 726/2004, and
(ii) in the case of a product for sale or supply in Great Britain, regulation 49(1).”.”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/105 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-105
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.